Aspect gains brain monitoring technology
This article was originally published in Clinica
Executive Summary
Aspect Medical Systems has gained exclusive rights to commercialise new brain monitoring technology for depression, which was developed by the Neuropsychiatric Institute and the David Geffen School of Medicine at the University of California Los Angeles (UCLA).